Transpaco Limited (JSE:TPC)

CTI BioPharma Ratios and Metrics

Market cap in millions ZAR. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	1,035	880	928	646	509	460
Market Cap Growth	4.64%	-5.23%	43.73%	26.91%	10.51%	-28.21%
Enterprise Value	1,105	967	1,056	786	721	587
Last Close Price	35.90	28.68	26.85	16.28	11.52	9.40
PE Ratio	7.32	5.77	5.25	4.23	4.61	6.68
Forward PE	-	7.97	7.97	7.97	7.97	7.97
PS Ratio	0.42	0.35	0.36	0.28	0.25	0.24
PB Ratio	1.07	0.94	1.05	0.78	0.69	0.68
P/TBV Ratio	1.17	1.03	1.16	0.87	0.78	0.77
P/FCF Ratio	7.76	5.10	3.60	5.89	10.27	4.74
P/OCF Ratio	6.24	4.09	3.10	4.56	3.79	2.20
PEG Ratio	-	0.65	0.65	0.65	0.65	0.65
EV/Sales Ratio	0.45	0.39	0.41	0.34	0.35	0.31
EV/EBITDA Ratio	4.10	3.63	3.47	2.85	3.37	3.30
EV/EBIT Ratio	5.65	4.55	4.18	3.49	4.37	4.32
EV/FCF Ratio	8.28	5.61	4.10	7.16	14.55	6.04
Debt / Equity Ratio	0.14	0.13	0.21	0.25	0.33	0.22
Debt / EBITDA Ratio	0.52	0.42	0.57	0.68	1.02	0.72
Debt / FCF Ratio	1.05	0.69	0.71	1.85	4.91	1.55
Asset Turnover	1.68	1.70	1.78	1.70	1.71	1.73
Inventory Turnover	6.91	6.23	6.01	5.94	6.65	5.99
Quick Ratio	1.60	1.32	1.25	1.12	1.12	1.12
Current Ratio	2.36	2.14	2.10	1.94	1.96	1.92
Return on Equity (ROE)	15.27%	16.78%	20.62%	19.55%	15.60%	13.89%
Return on Assets (ROA)	8.41%	9.09%	10.86%	10.22%	8.47%	7.73%
Return on Capital (ROIC)	11.33%	12.54%	15.03%	14.03%	11.40%	10.73%
Return on Capital Employed (ROCE)	17.50%	20.10%	23.80%	22.10%	17.10%	16.50%
Earnings Yield	13.68%	17.34%	19.03%	23.64%	21.67%	14.98%
FCF Yield	12.89%	19.59%	27.78%	16.99%	9.74%	21.11%
Dividend Yield	6.68%	8.37%	9.68%	13.21%	13.28%	11.81%
Payout Ratio	48.88%	49.48%	42.80%	35.33%	36.08%	39.58%
Buyback Yield / Dilution	4.36%	5.98%	1.65%	3.24%	0.61%	-
Total Shareholder Return	11.04%	14.35%	11.33%	16.45%	13.89%	11.81%

Updated Feb 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.